Academic Journal
View in EDS

Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy

Bibliographic Details
Title: Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy
Authors: Emori, Tomoya, Itonaga, Masahiro, Ashida, Reiko, Tamura, Takashi, Kawaji, Yuki, Hatamaru, Keiichi, Yamashita, Yasunobu, Shimokawa, Toshio, Koike, Masataka, Sonomura, Tetsuo, Kawai, Manabu, Kitano, Masayuki
Source: In Pancreatology March 2022 22(2):277-285
Database: ScienceDirect
More Details
ISSN:14243903
DOI:10.1016/j.pan.2021.12.013
Published in:Pancreatology
Language:English